Finance

Lists
Why is CNSP down ७.४७%?
Dive Deeper
CNSP:NASDAQ
CNS Pharmaceuticals Inc
US$ ४.२१
-७.४७%
(-०.३४) 1D
नोभेम्बर ४, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNSP...
Open
US$ ४.३९
High
US$ ४.३९
Low
US$ ४.०६
Mkt. cap
६१.५३ लाख
Avg. vol.
१२.२२ हजार
Volume
०.००
52-wk high
US$ १०.५४
52-wk low
US$ १.९०
EPS
-US$ २३.१४
Beta
१.०१
Shares outstanding
१४.६१ लाख
No. of employees
८
Open
US$ ४.३९
High
US$ ४.३९
Low
US$ ४.०६
Mkt. cap
६१.५३ लाख
Avg. vol.
१२.२२ हजार
Volume
०.००
52-wk high
US$ १०.५४
52-wk low
US$ १.९०
EPS
-US$ २३.१४
Beta
१.०१
Shares outstanding
१४.६१ लाख
No. of employees
८
News stories
From web sources and news partners
About CNS Pharmaceuticals Inc
CEO-
Employees८
Founded२०१७
Headquartersह्युस्टन, टेक्सस, संयुक्त राज्य अमेरिका
Sector-
Industry-
Websitecnspharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ १०.००
+१३७.५%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२१.९७ लाख
३१.६५ लाख
३५.४४ लाख
१२.०१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१०.५७ लाख
२८.२१ लाख
१४.३१ लाख
१४.९९ लाख
Operating expense
३२.५३ लाख
५९.८६ लाख
४९.७५ लाख
२७.०० लाख
Total operating expenses
३२.५३ लाख
५९.८६ लाख
४९.७५ लाख
२७.०० लाख
Operating income
-३२.५३ लाख
-५९.८६ लाख
-४९.७५ लाख
-२७.०० लाख
Other non operating income
-
-२.५६ हजार
-
-
EBT including unusual items
-३२.१८ लाख
-५९.५६ लाख
-४९.३७ लाख
-२५.८८ लाख
EBT excluding unusual items
-३२.१८ लाख
-५९.५६ लाख
-४९.३७ लाख
-२५.८८ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३२.१८ लाख
-५९.५६ लाख
-४९.३७ लाख
-२५.८८ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
३७.०२ हजार
३५.६० हजार
४४.२७ हजार
१.१६ लाख
Interest expense
-२.१२ हजार
-२.७२ हजार
-६.११ हजार
-४.०० हजार
Net interest expenses
३४.९१ हजार
३२.८८ हजार
३८.१६ हजार
१.१२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३२.५३ लाख
-५९.८५ लाख
-४९.७३ लाख
-२६.८९ लाख
Gain or loss from assets sale
-
२.५६ हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू